 CLEVELAND--BUSINESS WIRE--Athersys, Inc. NASDAQ: ATHX, a regenerative medicine company developing MultiStem invimestrocel for critical care indications, announced today it will host a business update conference call on October 6, 2022 at 4:00 pm Eastern Time. Dan Camardo, Chief Executive Officer, Maia Hansen, Chief Operating Officer, Kasey Rosado, Interim Chief Financial Officer, and Robert Willie Mays, Executive Vice President Regenerative Medicine and Head of Neuroscience, will provi 